Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 11 | 2025 | 230 | 2.000 |
Why?
|
| Kidney Neoplasms | 12 | 2025 | 414 | 1.900 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2024 | 76 | 0.930 |
Why?
|
| Testicular Neoplasms | 2 | 2024 | 111 | 0.920 |
Why?
|
| Nephrectomy | 6 | 2025 | 163 | 0.900 |
Why?
|
| Seminoma | 1 | 2024 | 20 | 0.800 |
Why?
|
| Nomograms | 2 | 2025 | 59 | 0.420 |
Why?
|
| Lymph Node Excision | 2 | 2024 | 173 | 0.380 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2025 | 1150 | 0.370 |
Why?
|
| C-Reactive Protein | 2 | 2024 | 423 | 0.350 |
Why?
|
| Neoplasm Staging | 4 | 2025 | 1474 | 0.270 |
Why?
|
| Lymphatic Metastasis | 2 | 2025 | 336 | 0.250 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2025 | 12 | 0.220 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2025 | 13 | 0.220 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2025 | 27 | 0.220 |
Why?
|
| Retrospective Studies | 12 | 2025 | 17325 | 0.220 |
Why?
|
| Registries | 2 | 2024 | 2410 | 0.220 |
Why?
|
| Retroperitoneal Space | 1 | 2024 | 18 | 0.200 |
Why?
|
| Urology | 1 | 2024 | 63 | 0.200 |
Why?
|
| Lymphocytes | 1 | 2025 | 376 | 0.190 |
Why?
|
| Physicians, Women | 1 | 2024 | 90 | 0.190 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2025 | 337 | 0.190 |
Why?
|
| Teratoma | 1 | 2024 | 124 | 0.190 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2025 | 971 | 0.180 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 171 | 0.180 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2025 | 258 | 0.180 |
Why?
|
| Databases, Factual | 2 | 2025 | 1491 | 0.180 |
Why?
|
| Medical Oncology | 1 | 2024 | 340 | 0.170 |
Why?
|
| Robotic Surgical Procedures | 1 | 2024 | 185 | 0.170 |
Why?
|
| Survival Rate | 4 | 2025 | 2094 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2024 | 900 | 0.150 |
Why?
|
| Neutrophils | 1 | 2025 | 1125 | 0.150 |
Why?
|
| Machine Learning | 1 | 2025 | 587 | 0.150 |
Why?
|
| Prognosis | 5 | 2025 | 4329 | 0.150 |
Why?
|
| Aged | 11 | 2025 | 26215 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2024 | 686 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 668 | 0.130 |
Why?
|
| Middle Aged | 11 | 2025 | 36302 | 0.120 |
Why?
|
| Male | 12 | 2025 | 73003 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2024 | 11793 | 0.110 |
Why?
|
| Humans | 16 | 2025 | 145763 | 0.100 |
Why?
|
| Female | 12 | 2025 | 79035 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2025 | 2977 | 0.090 |
Why?
|
| Biomarkers | 1 | 2024 | 4302 | 0.090 |
Why?
|
| Quality of Life | 1 | 2024 | 3210 | 0.080 |
Why?
|
| Comorbidity | 2 | 2025 | 1662 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 1329 | 0.060 |
Why?
|
| Platelet Count | 1 | 2025 | 94 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2025 | 165 | 0.060 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2025 | 118 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 508 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2024 | 222 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2024 | 328 | 0.050 |
Why?
|
| Necrosis | 1 | 2024 | 244 | 0.050 |
Why?
|
| United States | 3 | 2025 | 16123 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 195 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2025 | 196 | 0.050 |
Why?
|
| Forecasting | 1 | 2024 | 390 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 618 | 0.040 |
Why?
|
| DNA Damage | 1 | 2025 | 437 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 8346 | 0.040 |
Why?
|
| Cell Survival | 1 | 2025 | 1103 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2025 | 379 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1330 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2024 | 509 | 0.040 |
Why?
|
| Adult | 4 | 2025 | 40872 | 0.040 |
Why?
|
| Fibrosis | 1 | 2024 | 561 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2024 | 1378 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10917 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 765 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2123 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 1359 | 0.030 |
Why?
|
| Age Factors | 1 | 2025 | 3346 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3551 | 0.030 |
Why?
|
| Kidney | 1 | 2024 | 1496 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3752 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 6032 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 14251 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 38097 | 0.010 |
Why?
|